Insmed(US:INSM) Prnewswireยท2024-10-17 12:00Core Points - Insmed Incorporated will release its third-quarter 2024 financial results on October 31, 2024 [1] - A conference call for investors will be held on the same day at 8:00 a.m. ET to discuss the financial results and provide a business update [2] - The conference call will be accessible via phone and will also be webcast live on the company's website [2] Company Overview - Insmed is a global biopharmaceutical company focused on delivering first- and best-in-class therapies for serious diseases [4] - The company has a diverse portfolio of approved and investigational medicines, particularly in pulmonary and inflammatory conditions [4] - Insmed is recognized as one of the best employers in the biopharmaceutical industry, having been ranked as the No. 1 Science Top Employer for three consecutive years [5]